miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 26, 2025

HP outlines $1B AI-driven savings target and projects $2.8B-$3B FY26 free cash flow as memory costs rise

View original at seekingalpha.com
HP outlines $1B AI-driven savings target and projects $2.8B-$3B FY26 free cash flow as memory costs rise Earnings Call Insights: HP Inc…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Pricing actions will happen across the board but more selectively or higher or lower depending on specific situations

    80% confidence
  • Memory costs are currently 15% to 18% of the cost of a typical PC, and while an increase was expected, its rate has accelerated in the last few weeks

    80% confidence
  • Memory costs are currently 15% to 18% of the cost of a typical PC, and while an increase was expected, its rate has accelerated in the last few weeks

    80% confidence
  • Pricing actions will happen across the board but more selectively or higher or lower depending on specific situations

    80% confidence
  • HP delivered its sixth consecutive quarter of revenue growth, up 4% year-over-year largely driven by Personal Systems gains in commercial and consumer

    80% confidence
  • Non-GAAP EPS came above the midpoint of guidance

    80% confidence
  • Free cash flow is expected to be relatively flat with slightly lower earnings offset by improvements in working capital due to favorable cash conversion cycle from growing PS business

    80% confidence
  • HP maintained #1 market share in Print despite 4% revenue decline

    80% confidence
  • HP surpassed its original $1.4 billion savings target, ultimately delivering $2.2 billion in cumulative gross annualized savings

    80% confidence
  • HP is confident in the strength of organization and partnerships built with suppliers to deliver the best possible outcome for shareholders

    80% confidence
  • HP delivered its sixth consecutive quarter of revenue growth, up 4% year-over-year largely driven by Personal Systems gains in commercial and consumer

    80% confidence
  • HP will mitigate memory costs through qualifying lower-cost suppliers, redesigning products, accelerating AI-enabled cost savings, and raising prices

    80% confidence
  • HP surpassed original $1.4 billion savings target, ultimately delivering $2.2 billion in cumulative gross annualized savings

    80% confidence
  • HP maintained #1 market share in print and saw double-digit growth in Consumer Subscriptions

    80% confidence
  • HP delivered another quarter of solid performance to close out the fiscal year with operating margins within expected ranges for both businesses and non-GAAP EPS slightly above the midpoint of guidance

    80% confidence
  • HP expects approximately $300 million in AI-driven cost savings by end of FY26

    80% confidence
  • Pricing increases will happen across the board but more selectively or higher or lower depending on specific situations

    80% confidence
  • Non-GAAP EPS came above the midpoint of guidance

    80% confidence
  • HP will implement pricing increases across the board but more selectively depending on specific situations

    80% confidence
  • Consumer Subscriptions now nearing $1 billion in annual revenue with double-digit growth

    80% confidence
  • HP is confident in the strength of the organization and partnerships built with suppliers to deliver the best possible outcome for shareholders

    80% confidence
  • HP surpassed its original $1.4 billion savings target, ultimately delivering $2.2 billion in cumulative gross annualized savings

    80% confidence
  • Over 30% of HP's shipments are now AI PCs

    80% confidence
  • Over 30% of PC shipments are now AI PCs

    80% confidence
  • HP surpassed original $1.4 billion savings target, ultimately delivering $2.2 billion in cumulative gross annualized savings

    80% confidence
  • FY26 free cash flow expected to be relatively flat with slightly lower earnings offset by improvements in working capital

    80% confidence
  • The new cost savings initiative is driven by the opportunity that AI will bring to accelerate product development, improve customer satisfaction and boost productivity

    80% confidence
  • HP delivered operating margins within expected ranges for both businesses and non-GAAP EPS slightly above the midpoint of guidance range

    80% confidence
  • HP is setting guidance at a level they have high confidence in meeting and hopefully exceeding

    80% confidence
  • AI-driven cost savings initiative is really driven by the opportunity AI will bring to accelerate product development, improve customer satisfaction and boost productivity

    80% confidence

Data points we hold from this source

HP Inc. · memory cost percentage15-18 percent
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
HP outlines $1B AI-driven savings target and projects $2.8B-$3B FY26 free cash flow as memory costs rise — Source | Via News | es.VIA.NEWS